1247294

AstraZeneca Pharmaceuticals LP — FEI 2518137

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 4, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wilmington, DE (United States)

Additional Details

Sponsor, Contract Research Organization